Article
<i>In silico</i> repurposed drugs against monkeypox virus
2022-07-18
Abstract excerpt
Monkeypox is an emerging epidemic of concern. The disease is caused by the monkeypox virus and an increasing global incidence with a 2022 outbreak that has spread to Europe amid the COVID-19 pandemic. The new outbreak is associated with novel, previously undiscovered mutations a nd variants. Currently the US Food and Drug Administration (FDA) approved poxvirus treatment involves use of tecovirimat. However, there...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d13aeee0-eb85-598e-9d92-18e7b901decd
- DOI
- 10.1101/2022.07.17.500371
